Atrás
Rango del Día
$7.75
$8.30
Rango de 52 Semanas
$7.75
$17.85
Volumen
100
Promedio 50D / 200D
$9.79
/
$11.04
Cierre Anterior
$7.75
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -0.3 | 0.3 |
| P/B | 0.0 | 2.9 |
| ROE % | -6.9 | 3.7 |
| Net Margin % | -20.2 | 3.8 |
| Rev Growth 5Y % | 18.6 | 10.0 |
| D/E | 0.3 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$220.23
$120.98 – $342.51
|
79 B | 1 |
| FY2029 |
$141.75
$77.87 – $220.45
|
61 B | 1 |
| FY2028 |
$118.08
$64.87 – $183.64
|
53 B | 1 |
Puntos Clave
Revenue grew 18.61% annually over 5 years — strong growth
Earnings declined -124.99% over the past year
Debt/Equity of 0.33 — conservative balance sheet
Negative free cash flow of -14.93B
PEG of 0.54 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 78.90%
Crecimiento
Revenue Growth (5Y)
18.61%
Revenue (1Y)-60.29%
Earnings (1Y)-124.99%
FCF Growth (3Y)N/A
Calidad
Return on Equity
-6.93%
ROIC-5.44%
Net Margin-20.24%
Op. Margin-26.86%
Seguridad
Debt / Equity
0.33
Current Ratio1.66
Interest Coverage-9.94
Valoración
P/E Ratio
-0.27
P/B Ratio0.02
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -60.29% | Revenue Growth (3Y) | -16.91% |
| Earnings Growth (1Y) | -124.99% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 18.61% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 18.54B | Net Income (TTM) | -3.75B |
| ROE | -6.93% | ROA | -4.87% |
| Gross Margin | 40.61% | Operating Margin | -26.86% |
| Net Margin | -20.24% | Free Cash Flow (TTM) | -14.93B |
| ROIC | -5.44% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.33 | Current Ratio | 1.66 |
| Interest Coverage | -9.94 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -0.27 | P/B Ratio | 0.02 |
| P/S Ratio | 0.05 | PEG Ratio | 0.54 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.00B | Enterprise Value | -10.65B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 18.54B | 46.68B | 26.85B | 9.37B | 11.68B |
| Net Income | -3.75B | 15.01B | 7.55B | 3.61B | 4.45B |
| EPS (Diluted) | -29.80 | 115.68 | 58.14 | 19.81 | 34.26 |
| Gross Profit | 7.53B | 34.50B | 18.11B | 7.01B | 9.53B |
| Operating Income | -4.98B | 21.11B | 8.98B | 4.42B | 6.99B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 77.10B | 92.77B | 63.87B | 26.62B | 26.27B |
| Total Liabilities | 25.53B | 36.01B | 31.82B | 1.62B | 5.05B |
| Shareholders' Equity | 51.57B | 56.76B | 32.04B | 25.00B | 21.22B |
| Total Debt | 17.06B | 19.63B | 21.05B | 0.0 | 0.0 |
| Cash & Equivalents | 28.71B | 48.12B | 5.25B | 11.75B | 7.15B |
| Current Assets | 38.95B | 57.21B | 25.07B | 13.86B | 15.64B |
| Current Liabilities | 23.44B | 18.41B | 11.03B | 1.27B | 4.71B |